The purpose of our study was to investigate the immunohistochemical expression of TGF-β1 and p27 in pancreatic adenocarcinomas and to compare the findings with the clinicopathological features and survival. The gene discussed is CDKN1B; the disease is pancreatic adenocarcinoma.